Literature DB >> 165675

Regulation of cyclic GMP levels in the ductus deferens of the rat.

G Schultz, J G Hardman.   

Abstract

The cyclic GMP level in the ductus deferens is elevated by acetylcholine, norepinephrine, KCl, and the phosphodiesterase inhibitor SC-2964. The presence of extracellular Ca++ is required for the effects of all of these agents on cyclic GMP levels. In addition, Ca++ appears to be an important factor for the basal turnover of cyclic GMP in this tissue, but it may be less important in other tissues. These observations have led us to the following working hypothesis (Fig. 5): The interactions of some hormones or neurotransmitters with membrane receptors secondarily increase cyclic GMP formation after primarily increasing the influx of extracellular Ca++ or changing the distribution of Ca++ among intracellular pools or compartments. However, in addition to this possibility, other hormonal effects on particulate and/or soluble guanylate cyclase that do not involve Ca++ mediation must also be considered. Some agents that are known to increase cyclic GMP in tissues have been reported in preliminary communications to activate cell-free preparations of guanylate cyclase (Amer and McKINNEY, 1973; White, Ignarro, and George, 1973), but these reports have not yet been confirmed by other laboratories. Secretin has been reported to stimulate guanylate cyclase activity from several tissues (Thompson, Johnson, Lavis, and Williams, 1974), but the significance of this report is unclear since secretin has not yet been shown to increase cyclic GMP levels in any tissue. Thus, although not convincingly established, some hormones may increase particulate guanylate cyclase activity in a manner similar to that by which hormones increase adenylate cyclase activity. Alternatively, some hormones may increase soluble guanylate cyclase activity with mediating factors other than Ca++ being involved, or hormone-receptor interaction at the plasma membrane could conceivably induce a dislocation and change in effective activity of a reversibly bound, membrane-associated guanylate cyclase. Elucidating which or how many of these possibilities are operative will require thorough study and understanding of the fundamental behavior and properties of soluble and particulate guanylate cyclase activities.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165675

Source DB:  PubMed          Journal:  Adv Cyclic Nucleotide Res        ISSN: 0084-5930


  5 in total

1.  Agonist induced release of intracellular Ca2+ in the rabbit aorta.

Authors:  R Deth; C van Breemen
Journal:  J Membr Biol       Date:  1977-01-28       Impact factor: 1.843

2.  Effects of manganese on cyclic GMP levels in the rat ductus deferens.

Authors:  K D Schultz; K Schultz; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-07       Impact factor: 3.000

3.  Alterations of pulmonary vascular resistance and pulmonary cyclic nucleotide metabolism in the hypoxic pig.

Authors:  E Kaukel; W Beier; K Lanser; V Sill
Journal:  Basic Res Cardiol       Date:  1977 Sep-Oct       Impact factor: 17.165

4.  The role of extracellular Ca2+ and cyclic nucleotides in the mechanism of enzyme secretion from the cat pancreas.

Authors:  I Schulz
Journal:  Pflugers Arch       Date:  1975-10-28       Impact factor: 3.657

5.  3':5'-cyclic AMP-dependent 3':5'-cyclic GMP accumulation in Dictyostelium discoideum.

Authors:  J M Mato; F A Krens; P J van Haastert; T M Konijn
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.